Clinical Research

New Step by Step Map For clinical research denver | 3/26/2020

New Step by Step Map For clinical research denver New Step by Step Map For clinical research denver Category: Blog These primitive cells have an capacity to differentiate into lots of cell types and could become Pretty much any specialised type of cells in the human human body to market tissue repair service and recovery, to perhaps receive final results with minimum or no Unintended effects.Individuals who go after People …

Medocity launches COVID-19 digital platform with Hillcrest Home Care enabling large-scale population screening, surveillance, remote monitoring and virtual interventions | PRWeb | 3/26/2020

… may reduce the need for in-person visits and decrease the risk of coronavirus exposure. During this uncertain time, Medocity’s highly configurable, cloud-based digital platform allows any sponsor - including health care providers, payers, clinical research ers or public health agencies - to easily and quickly go virtual.” About Hillcrest Home Care Hillcrest Home Care offers skilled medical home health and telehealth services to aging adults in 11 counties in Nebraska and …

Follow Clinical Research:    

Siamese neural networks for continuous disease severity evaluation and change detection in medical imaging | Nature | 3/26/2020

… by domain experts, which can lead to changes in clinical management 3 , 4 . Thus, grading disease severity and evaluating change on a continuous spectrum has the potential to add value to patient care and clinical research . Deep learning is a powerful approach for automating tasks within medical imaging 5 , 6 . However, most of the published literature has focused on the prediction of absolute labels, with binning of patient images into …

MIG USA, a North Carolina Company, to Bring Needed Relief Through the Provision of Coronavirus Test Kits | Business Wire | 3/26/2020

HIGH POINT, N.C.- MIG USA, LLC (Mjalli Investment Group), a High Point, North Carolina company having focus in the biotechnology, pharmaceutical, and clinical research sectors, along with its corporate partner, have acquired the exclusive rights to manufacture and distribute a rapid-result coronavirus test kit, the VITAK-19, for immediate availability to local, national and worldwide medical communities. The company now has a substantial quantity of test kits to supply …

The Occurrence and Longitudinal Changes of Cognitive Impairment After Acute Ischemic Stroke | 3/26/2020

… ICONS) Investigators 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2 Department of Neuropsychology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 3 National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 4 Department of Medicine, Eisai China INC, Shanghai, People’s Republic of ChinaCorrespondence: Yong-jun WangDepartment of Neurology, Beijing Tiantan …

ClinOne’s Remote Clinical Trial Patient Management Technology Allows Pharmaceutical Companies to Continue Clinical Research Efforts Amidst the Covid-19 Pandemic in Accordance with FDA Guidelines | 3/26/2020

DENVER–(BUSINESS WIRE)–The Covid-19 pandemic has shined a bright light on the need to manage patients remotely wherever possible. This need is especially acute in clinical trials as identified by the FDA. Trial sponsors, physicians and regulators are now embracing the use of technology to support patients and sites involved in clinical trials in ways needed to preserve the viability of the worldwide clinical trial system. “The FDA’s …

SOPHiA GENETICS and Paragon Genomics Join Forces Against the COVID-19 Coronavirus Pandemic | PR Newswire | 3/26/2020

… health tech company democratizing Data-Driven Medicine to improve health outcomes and economics worldwide. By unlocking the power of new-generation health data for cancer and rare diseases management, the universal SOPHiA Platform allows clinical research ers to act with precision and confidence. The company’s innovative approach enables an ever-expanding community of over 1’000 institutions to benefit from knowledge sharing, fostering a new era in healthcare. SOPHiA’s achievement is …

Elsevier Launches Veridata™ Electronic Data Capture (EDC) and Offers Free Access to Help Researchers Studying COVID-19 | PR Newswire | 3/26/2020

Sverige Elsevier Launches Veridata™ Electronic Data Capture (EDC) and Offers Free Access to Help Researchers Studying COVID-19 New resource allows clinical research ers to capture clinical trial data in a secure environment, accelerating research and ultimately improving outcomes for patients News provided by Mar 26, 2020, 10:42 ET Share this article NEW YORK , March 26, 2020 /PRNewswire/ – Elsevier , a global leader in information analytics specializing in science and health, today …

Coronavirus Will Slow Down Global Drug Development, a New Survey by Clinical Research IO Predicts | PR Newswire | 3/26/2020

… monitoring by pharmaceutical sponsors and their agents, thus inhibiting the ability of sponsors to perform effective oversight. “This is one of the second-order casualties of the covid crisis,” said Raymond Nomizu , CEO of Clinical Research IO, the clinical trials software vendor that administered the survey. “When we look back five years from now, I fully expect to see a drop in the number of breakthrough new medications being approved …

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis | Business Wire | 3/26/2020

… option to offer my RMS patients that has demonstrated efficacy and safety,” 1 said Bruce Cree, M.D., Ph.D., M.A.S., professor of clinical neurology, University of California San Francisco (UCSF) Weill Institute for Neurosciences and clinical research director, UCSF MS Center. “Multiple sclerosis is an unpredictable and often disabling disease that affects nearly one million people in the United States. 9,12 Ongoing treatment with disease-modifying therapy can reduce the number …

New Frontier Health Corporation Announces Fourth Quarter and Fiscal 2019 Financial Results | Business Wire | 3/26/2020

… approval from the China Food and Drug Administration (CFDA), which allows the hospital to conduct clinical drug trials, providing an excellent opportunity for additional growth as well as for gaining enhanced recognition as a clinical research institution. Oncology service also grew 28% yoy. Moreover, UFH’s Beijing clinical network added two international school nursing clinics in 2019. (2) PXU : Shanghai Puxi United Family Hospital (“PXU”) and its associated clinics recorded 3.3 …

Obituaries 03-26-2020 | 3/26/2020

… and their families with empathy, compassion, skill, and consideration. He had a keen mind, not only keeping up with medical advances, but reading numerous novels and appreciating music, art, politics, and sports. A successful clinical research er and respected sought after teacher and mentor for many students and colleagues, Dan was above all a “mensch”, a prince among men. He will be greatly missed. Funeral services were held in Atlanta, Georgia …

How to know if your business is essential during “Stay Home” order | WIN 98.5 | 3/26/2020

… are deemed essential by the Michigan government, and each of the included examples come from the guidance of U.S. officials. Health care and public health - Workers providing COVID-19 testing; Workers that perform critical clinical research needed for COVID-19 response; caregivers. Law enforcement, public safety, and first responders - Personnel in emergency management, law enforcement, Emergency Management Systems, fire, and corrections, including front line and management; 911 call center employees …

Medical Marijuana, Inc. CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19 on Cannabis Industry | PR Newswire | 3/26/2020

… space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds® ; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc . and Kannalife, Inc . Medical Marijuana, Inc. was named a top CBD producer by CNBC . Medical Marijuana, Inc …

Detailed Insights into In Silico/Computer-Aided Drug Discovery Services Market to 2030 - Elaborate Profiles of Key Industry Players - ResearchAndMarkets.com | Malvern Daily Record | 3/26/2020

… USD 4-10 billion. Moreover, it is well-known that only a small proportion of leads, which are selected for further investigation during the initial stages of research, are actually translated into product candidates for clinical research studies. Over time, the complexities of drug discovery, have increased; this is especially true for large molecules, which are inherently more complex than conventional small molecule drugs. As a result, there has been a …

Broad Institute’s CLIA-certified testing center begins processing COVID-19 patient samples; is named a Massachusetts state reference lab | 3/26/2020

… Polito Administration’s COVID-19 Response Command Center, to create partnerships spanning government, academia, and the private sector to quickly grow the ability to test and support patients during the ongoing COVID-19 pandemic. The Clinical Research Sequencing Platform, LLC (CRSP) is a subsidiary of the Broad Institute. CLIA-certified and CAP (College of American Pathologists) accredited, it can return data to physicians for use in diagnostics, patient care, and clinical …

Elsevier Launches Veridata Electronic Data Capture (EDC) and Offers Free Access to Help Researchers | 3/26/2020

Analytics , Life Sciences , News Leave a comment 4 Views New resource allows clinical research ers to capture clinical trial data in a secure environment, accelerating research and ultimately improving outcomes for patients Elsevier , a global leader in information analytics specializing in science and health, introduces Veridata EDC, a secure, compliant and user-friendly platform to capture patient data for clinical research . Veridata EDC is a next-generation version of Elsevier’s MACRO …

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis | BioSpace | 3/26/2020

… option to offer my RMS patients that has demonstrated efficacy and safety,” 1 said Bruce Cree, M.D., Ph.D., M.A.S., professor of clinical neurology, University of California San Francisco (UCSF) Weill Institute for Neurosciences and clinical research director, UCSF MS Center. “Multiple sclerosis is an unpredictable and often disabling disease that affects nearly one million people in the United States. 9,12 Ongoing treatment with disease-modifying therapy can reduce the number …

Research Priorities for Heart Failure With Preserved Ejection Fraction | Circulation | 3/26/2020

… among basic, translational, clinical, and epidemiological scientists and across organ systems and cell types, leveraging different areas or research focus, and between research centers. A network of collaborative centers to accelerate basic, translational, and clinical research of pathobiological mechanisms and treatment strategies in HFpEF was discussed as an example of a strategy to advance research progress. This resource would facilitate comprehensive, deep phenotyping of a multicenter HFpEF patient cohort with …

Who can you contact for FDA regulatory and clinical trial advisory support during the coronavirus pandemic? | 3/26/2020

Who can you contact for FDA regulatory and clinical trial advisory support during the coronavirus pandemic? 26 March 2020 MCRA , a medical device advisory firm which specialises in regulatory affairs, clinical research , reimbursement, compliance, and quality assurance, has implemented a call centre for medical device manufacturers. × Expand The centre aims to keep manufacturers informed of government and site decisions that will potentially impact regulatory submissions, clinical study operations, or quality …

Population Health

Medocity launches COVID-19 digital platform with Hillcrest Home Care enabling large-scale population screening, surveillance, remote monitoring and virtual interventions | PRWeb | 3/26/2020

… symptoms Facilitate timely escalation of care as changes in health status are noted Track and report evolving COVID-19 related population health statistics and trends over time to ensure resources are appropriately deployed “The Medocity … digital platform allows any sponsor - including health care providers, payers, clinical researchers or public health agencies - to easily and quickly go virtual.” About Hillcrest Home Care Hillcrest Home Care offers skilled medical home health and …

John Theurer Cancer Center Launches Clinical Trial of Personalized Cancer Vaccine Using New Gene-Based Technology for High-Risk Melanoma | 3/26/2020

… similar positive outcome for these patients.” “Participation in groundbreaking studies such as these demonstrates John Theurer Cancer Center’s leadership in clinical research,” added Andre Goy, M.D., MS, chair and executive director of John Theurer Cancer … executive, Hackensack University Medical Center and executive vice president of Population Health, Hackensack Meridian Health . “We look forward to seeing how this innovative vaccine and advances in immunotherapy will help us expand treatment options for …

Telehealth

Medocity launches COVID-19 digital platform with Hillcrest Home Care enabling large-scale population screening, surveillance, remote monitoring and virtual interventions | PRWeb | 3/26/2020

… Article To help slow the spread of COVID-19, Hillcrest Home Care, one of Nebraska’s largest skilled home health and Telehealth agencies, will immediately begin real-time screening, remote monitoring and risk assessment of COVID … digital platform allows any sponsor - including health care providers, payers, clinical researchers or public health agencies - to easily and quickly go virtual.” About Hillcrest Home Care Hillcrest Home Care offers skilled medical home health and …

Visitor policy change in wake of COVID-19 | 3/26/2020

… committed to protecting our patients and staff and reducing the spread of COVID-19 in our community. We are expanding telehealth and virtual visits so patients can stay home and still get great care. We … and world-class chronic disease management. dedicated to care innovations, clinical research, health education and the support of community health …

Remote Monitoring

KORE Unveils New IoT Services for Enterprise Customers | 3/26/2020

remote monitoring and care of patients, KORE Life Sciences for the clinical research organizations, and pharma. That will allow them to launch and to manage the Electronic Clinical Outcome Assessment Solutions (eCOA) and Electronic Patient Recording Outcome solutions (ePRO). Further, the company unveiled KORE Assets, which is a delivery critical asset management solutions; KORE Fleet for delivering deep insights to the fleet managers. KORE also announced KORE Industrial IoT to …

Medocity launches COVID-19 digital platform with Hillcrest Home Care enabling large-scale population screening, surveillance, remote monitoring and virtual interventions | PRWeb | 3/26/2020

Medocity launches COVID-19 digital platform with Hillcrest Home Care enabling large-scale population screening, surveillance, remote monitoring and virtual interventions Share Article To help slow the spread of COVID-19, Hillcrest Home Care, one … digital platform allows any sponsor - including health care providers, payers, clinical researchers or public health agencies - to easily and quickly go virtual.” About Hillcrest Home Care Hillcrest Home Care offers skilled medical home health and …

Digital Health

MCRA Launches Medical Device U.S. FDA Regulatory & Clinical Trial Advisory Support & Call Center to Assist with the COVID-19 Pandemic | PR Newswire | 3/24/2020

WASHINGTON MCRA, LLC, a leading medical device advisory firm and CRO with specialization in regulatory affairs, clinical research, reimbursement, compliance, and quality assurance, has implemented a call center to keep medical device manufacturers informed of … orthopedics, spine, cardiovascular, diagnostic imaging, wound care, dental, general healthcare, digital health, neurology, robotics, in vitro diagnostic (IVD) devices, personal protective equipment, test kits for clinic and at home uses, ventilators, cardiopulmonary monitoring systems, and …

MCRA Launches Medical Device U.S. FDA Regulatory & Clinical Trial Advisory Support & Call Center to Assist with the COVID-19 Pandemic | BioSpace | 3/24/2020

… WASHINGTON , March 24, 2020 /PRNewswire/ – MCRA, LLC, a leading medical device advisory firm and CRO with specialization in regulatory affairs, clinical research, reimbursement, compliance, and quality assurance, has implemented a call center to keep medical … orthopedics, spine, cardiovascular, diagnostic imaging, wound care, dental, general healthcare, digital health, neurology, robotics, in vitro diagnostic (IVD) devices, personal protective equipment, test kits for clinic and at home uses, ventilators, cardiopulmonary monitoring systems, and …

Mental Health

The Quinism Foundation Warns of Dangers from Use of Antimalarial Quinolines Against COVID-19 | PRWeb | 3/20/2020

… Nevin noted that during World War II-era studies, when many antimalarial drugs of the quinoline class were first synthesized, clinical researchers found that many caused a syndrome marked by psychosis, confusion, dizziness, and other … may be tempting to attribute anxiety, depression, paranoia, or other mental health symptoms to the psychological effects of the COVID-19 pandemic, “ said Dr. Nevin, “these symptoms may be an early warning sign of idiosyncratic …

Why we should learn to accept the coronavirus craziness | LA Times | 3/20/2020

… plan for the future, and when that future becomes difficult to imagine, it can take a significant toll on our mental health, Holman said. “If you sense that you don’t have a future, you don’t … Skalij / Los Angeles Times) Advertisement Vaile Wright , a director of clinical research at the American Psychological Assn., said that while we may not like this new reality we find ourselves in, we can learn to …

Regenerative Medicine

Dr. Adam Anz: Stem cells, BMA show promise in orthopedics but PRP has ‘largest body of work’ | 3/18/2020

… medicine specialist at Gulf Breeze, Fla.-based Andrews Institute for Orthopaedics & Sports Medicine. Serving as director of the Andrews Institute Regenerative Medicine Center, Dr. Anz oversees the ATC Fellowship Program at the Andrews Research & Education … half of these individuals. It was an exciting result. The clinical research organization recommended we stop because we achieved statistical significance. So, our next step is to ask the FDA what they would like us …

How ‘pioneer’ protein turns stem cells into organs | Phys Org | 3/18/2020

… Zaret, Ph.D., the Joseph Leidy Professor in the Department of Cell and Developmental Biology and Director of Penn’s Institute for Regenerative Medicine (IRM). “That opening allows other specialized, regulatory proteins to access the DNA and … how to control the process of cell development for both clinical research and therapeutic purposes. Zaret’s lab previously discovered pioneer factors in 2002 and has been working to better understand their function and role in …

Gut Microbiome

Nutritional approaches for treatment of Major Depressive Disorder | 3/18/2020

clinical research supporting the use of diet for treating depression. As we elucidate the mechanisms of inflammation, the gut microbiome, and their contribution to mental health, dietary manipulation is surely on its way. The anti-inflammatory diet, which recommends high fish intake, is commonly recommended to patients for a variety of health conditions due to its favorable omega-3 to omega-6 ratio. A healthy omega-3 to omega-6 …

What Contributes To Chronic Discomfort In Phoenix? | 3/14/2020

clinical research study shows that your body’s health and your psychological health are a lot more linked than initially impression. Some common instances of this are the link between the mind and also the gut microbiome. Chronic soreness might supply one more home window right here. Keep in mind that certain natural chemical we just spoke about. As things end up, it’s likewise produced extra for individuals that have long …

Patient Satisfaction

Are Clinical Trials Doing Enough to Assess Patient Quality of Life? | Patient Engagement HIT | 3/9/2020

Patient Satisfaction News Are Clinical Trials Doing Enough to Assess Patient Quality of Life? Data shows that clinical researchers don’t collect quality of life information for long enough during the clinical trial period. Source: Getty Images By March 09, 2020 - Quality of life is only measured during the intervention stage of a clinical trial, according to a study published in JAMA Network Open , raising questions about how researchers gather patient …

Dual Degrees | 3/6/2020

… If you have an understanding of the business side of medicine, you can do things more efficiently, which also improves patient satisfaction and patient care.” Speaking the Language While some doctors prefer to focus on … and fellowships, she was asked to apply her knowledge of clinical research to evaluating lasers and other new technologies. “My ability to analyze data, both clinical and scientific, to find the epidemiology of a health …

COVID-19

NIH Awards Booz Allen $147M IT Support Contract | Business Wire | 2/24/2020

… diseases, and also rapidly responds to the emergence or reemergence of infectious diseases like influenza, malaria and, more recently, Coronavirus (COVID-19). The NIAID has selected Booz Allen as a strategic partner in furthering the … management, machine learning, open source platforms, and specific knowledge of clinical research and the systems required to support it. “The National Institute of Allergy and Infectious Diseases plays a vital role in protecting public health …

NIH NIAID Awards Booz Allen Hamilton $147M Support Contract to Protect Public Health Around the World; Roman Salasznyk Quoted | 2/24/2020

clinical research and the systems required to support it. Through the contract, the NIAID will better understand, treat and prevent infectious, immunologic and allergic diseases, as well as improve the response to the emergence or reemergence of infectious diseases like influenza, malaria and Coronavirus (COVID-19). “With a unique blend of knowledge in life science and deep expertise in federal IT modernization, Booz Allen’s tremendous pool of talent is well …

Coronavirus

Drones. Disinfecting robots. ‘Contactless’ deliveries. The coronavirus outbreak is a test for China’s tech industry - CNN | 2/24/2020

… faced with a massive public health crisis , Beijing is pushing its tech companies to join the fight against the novel coronavirus. The country’s tech giants have responded to the outbreak by deploying autonomous vehicles to … news agency Xinhua . He added that China should ramp up clinical research for vaccines and antiviral drugs, as well as expand online shopping options for the tens of millions of people who are staying indoors …

More Vitamin C Studies Approved in China to Fight Coronavirus: Therapy Censored in U.S. | 2/24/2020

… 2020 we published a press release from Orthomolecular Medicine News Service regarding Vitamin C and its use in treating the Coronavirus. See: Vitamin C Protects Against Coronavirus It soon went viral on Facebook, until Facebook … Vitamin C can help combat the Coronavirus, when in fact clinical research trials are well underway in China with ample evidence that should be shared with the public, and not suppressed, simply because U.S. sources …

Electronic Caregiver

To fight coronavirus, Electronic Caregiver uses its own technology to keep employees safe | PR Newswire | 3/11/2020

PRNewswire/ – With the outbreak of COVID-19, known as the coronavirus, Electronic Caregiver ®, a 24/7 virtual care and health technology company, will begin using its own products to monitor the health of all its workers … Caregiver® and Addison Care™ are now involved in numerous official clinical research initiatives in clinical settings to further validate utilization and efficacy in areas of improved outcomes, improved treatment adherence and optimized continuum of care …

Merck

Merck’s KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (mTNBC) | 3/7/2020

… Tumors Expressed PD-L1 (CPS ≥10) Data to be Presented at an Upcoming Medical Congress and Discussed with Regulatory Authorities Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that … and healthy cells. Merck has the industry’s largest immuno-oncology clinical research program. There are currently more than 1,000 trials studying KEYTRUDA across a wide variety of cancers and treatment settings. The KEYTRUDA clinical program …

KEYNOTE-024 Meets PFS End Point in Patients With Classical Hodgkin Lymphoma | 3/4/2020

… Merck. 1 In addition to demonstrating a PFS benefit, there were no new safety signals observed with pembrolizumab in this study. The overall survival data were immature and therefore not included in the interim analysis.“Patients with classical Hodgkin lymphoma are generally young and when they do not achieve remission following standard treatment, their cancer is challenging to treat,” said Jonathan Cheng, MD, vice president, oncology clinical research, Merck Research …

Merck Research Laboratories

Merck’s KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (mTNBC) | 3/7/2020

… metastatic setting with this trial, and as neoadjuvant therapy in the KEYNOTE-522 trial,” said Dr. Roger M. Perlmutter, president, Merck Research Laboratories. “We look forward to sharing these findings with the medical community at … and healthy cells. Merck has the industry’s largest immuno-oncology clinical research program. There are currently more than 1,000 trials studying KEYTRUDA across a wide variety of cancers and treatment settings. The KEYTRUDA clinical program …

KEYNOTE-024 Meets PFS End Point in Patients With Classical Hodgkin Lymphoma | 3/4/2020

… clinical research, Merck Research Laboratories. These pivotal phase III data indicate a statistically significant and clinically meaningful improvement in progression-free survival with Keytruda compared, in head to head fashion, with the currently approved therapy of brentuximab vedotin. These data are strongly supportive of Keytruda’s current indication in cHL and we plan to file these data with regulatory authorities as quickly as is possible.” The interim analysis results follow positive …

Ambra Health

Ambra Health Partners With Perspectum | PR Newswire | 3/5/2020

NEW YORK , March 5, Ambra Health , makers of the leading cloud-based, medical image management suite, today announced a partnership with Perspectum , a global leader in the development of medical image analysis technologies. Perspectum’s flagship … Baptist Hospital as well as radiology practices, subspecialty practices, and clinical research organizations to dramatically improve imaging and collaborative care workflows. As expert partners, we listen to our customers, understand their needs, and apply our …

Ambra Health Partners With Perspectum | Markets Insider | Business Insider | 3/5/2020

NEW YORK , March 5, 2020 /PRNewswire/ – Ambra Health , makers of the leading cloud-based, medical image management suite, today announced a partnership with Perspectum , a global leader in the development of medical image analysis technologies … Baptist Hospital as well as radiology practices, subspecialty practices, and clinical research organizations to dramatically improve imaging and collaborative care workflows. As expert partners, we listen to our customers, understand their needs, and apply our …

CVS Health

Opportunities in Healthcare: A Q&A With Julie Yoo | 3/4/2020

… company focused on patient access. Julie was previously VP of Product at Generation Health, from its inception through acquisition by CVS Health; and a Product Manager at Knome, the world’s first whole genome sequencing service … truly works, even with the huge strides that scientific and clinical research communities have made in recent decades. This creates a shroud of existential uncertainty that will always pose some degree of risk to businesses …

Aural Analytics Appoints Four New Advisory Board Members | Business Wire | 2/6/2020

… president, regulatory affairs and quality assurance, Nalu Medical, Inc.; and Tyler Knutson , head of the data analytics hub, Aetna, a CVS Health Company, to its advisory board. “We are delighted to welcome Greg, Robert, Michele … and director, Arizona Alzheimer’s Consortium Stacy Rudnicki, M.D., senior director, clinical research, Cytokinetics Todd Schwedt, M.D., professor of neurology, chair of research, neurology, Mayo Clinic Jeremy Shefner, M.D., head of neurology, Barrow Neurological Institute About …

Medline

Clinical teaching unit design: a realist systematic review protocol of evidence-based practices for clinical education and health service delivery | BMJ | 2/28/2020

… and is therefore likely to generate outcomes relevant to policy change. The search strategy has been developed by academic and clinical research team members (including a medical sciences librarian) with content and methodological expertise. Given … intervention. Search strategy to identify relevant studies We searched Ovid MEDLINE (1946 to present, in-process and other non-indexed citations), Ovid Embase (1974 to 21 May 2019), Ovid EBM reviews—Cochrane Database of Systematic …

Different Effects of Structured Education on Glycemic Control and Psychological Outcomes in Adolescent and Adult Patients with Type 1 Diabetes: A Systematic Review and Meta-Analysis | 2/26/2020

Clinical Research Center for Metabolic Disease, Changsha, China 5 Clinic Nursing Teaching and Research Section, The Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China Show more Published 26 Feb 2020 Abstract Aim . This systematic review aimed at investigating the effectiveness of structured education (SE) in improving glycemic control and psychological outcomes in adolescent and adult patients with type 1 diabetes. Methods . Electronic databases (EMBASE, Medline, PubMed, and the …

Concerto HealthAI

Pfizer teams up with Saama for AI clinical data mining | FierceBiotech | 2/20/2020

clinical research partners.” RELATED: Saama closes $40M funding round for its clinical trial AI platform Pfizer, like many other Big Pharmas, has been seeking out AI tech firms to help with its trials and other research areas over the past five years. The New York giant has already enlisted Concerto HealthAI to apply real-world data to precision cancer medicine as well as Chinese tech startup XtalPi to develop an …

JPM: Concerto HealthAI unveils $150M raise, t2 pharma data collaborations | FierceBiotech | 1/16/2020

SAN FRANCISCO—Concerto HealthAI unveiled a steady drum beat of announcements at this year’s J.P. Morgan Healthcare Conference, including a $150 million funding round and separate real-world data partnerships with Big Pharma companies. That … revenue gains. “Concerto HealthAI is positioned to empower next-generation clinical research, accelerate breakthrough therapies, and improve patient outcomes.” RELATED: ASCO—Concerto HealthAI uses real-world data to fill the research gap among patients excluded …

electroCore

New Stimulating Device May Prevent Migraine | News, Sports, Jobs - Wheeling Intelligencer | 2/17/2020

… Feb 17, 2020 West Virginia University School of Medicine researcher Umer Najib is studying whether this neuromodulation device — made by electroCore — can prevent migraine in people who apply it to their necks three times a … or areas of the brain,” explained Najib, who directs the clinical research program for the School of Medicine’s Department of Neurology. In a new clinical trial he’s leading, neuromodulation takes the form of a cell …

Neuromodulation Device May Help Prevent Migraines | 1/31/2020

… system by applying electrical or magnetic pulses to specific nerves or areas of the brain,” explained Najib, who directs the clinical research program for the School of Medicine’s Department of Neurology. In a new clinical … every day, it prevents the migraine attacks from coming on.” ElectroCore—a corporation that specializes in neuromodulation technologies—makes the device and funded the trial. Previous animal studies and medical-imaging data suggest the device …

SOPHiA Genetics

BioSpace Movers & Shakers, Feb. 14 | BioSpace | 2/13/2020

… where he served as CMO. During his tenure at Pacira, Scranton successfully redesigned the company’s clinical trials process and oversaw clinical research and development, leading to the acceleration of several pipeline candidates as well as … joining Prescient, Shrivats was an Engagement Manager at L.E.K. Consulting. Sophia Genetics – Switzerland-based SOPHIA GENETICS named Philippe Menu as its new CMO. Menu spent the last eight years at McKinsey & Company, where he co …

SOPHiA GENETICS Appoints Chief Medical Officer to Accelerate the Execution of Medical Strategy | Business & Finance | manchestertimes.com | Business Wire | 2/13/2020

SOPHiA GENETICS Appoints Chief Medical Officer to Accelerate the Execution of Medical Strategy Feb 13, 2020 Save LAUSANNE, Switzerland & BOSTON–(BUSINESS WIRE)–Feb 13, 2020– SOPHiA GENETICS, leader in Data-Driven Medicine, announced today the … cancer and rare diseases management, the universal SOPHiA Platform allows clinical researchers to act with precision and confidence. The company’s innovative approach enables an ever-expanding community of over 1’000 institutions to benefit from …

Teva Pharmaceutical

EYLEA® (aflibercept) Injection Reduced Risk of Developing Vision-Threatening Events by 75% After Two Years in Patients with Diabetic Retinopathy | PR Newswire | 2/9/2020

… from PANORAMA were previously reported in October 2018 and February 2019 . A separate ongoing trial sponsored by the Diabetic Retinopathy Clinical Research Network known as Protocol W is also evaluating EYLEA for the treatment of … or collaboration agreement, including Regeneron’s agreements with Sanofi, Bayer, and Teva Pharmaceutical Industries Ltd. (or their respective affiliated companies, as applicable), to be cancelled or terminated without any further product success; and risks associated with …

EYLEA® (aflibercept) Injection Reduced Risk of Developing Vision-Threatening Events by 75% After Two Years in Patients with Diabetic Retinopathy | Markets Insider | Business Insider | 2/8/2020

… from PANORAMA were previously reported in October 2018 and February 2019 . A separate ongoing trial sponsored by the Diabetic Retinopathy Clinical Research Network known as Protocol W is also evaluating EYLEA for the treatment of … or collaboration agreement, including Regeneron’s agreements with Sanofi, Bayer, and Teva Pharmaceutical Industries Ltd. (or their respective affiliated companies, as applicable), to be cancelled or terminated without any further product success; and risks associated with …

Zacks Equity Research

What’s in the Offing for LabCorp’s (LH) Earnings in Q4? | Zacks | 2/7/2020

You follow Analyst Blog - edit You follow Zacks Equity Research - edit What would you like to follow? Zacks Equity Research Cancel Read More Hide Full Article Laboratory Corporation of America Holdings ( LH - Free Report ) also … fourth quarter. The transaction provides Covance with better global non-clinical research capabilities while maintaining access to bigger research models and services through a multi-year renewable supply agreement. Overall, for 2019, LabCorp expects year …

Here’s Why You Should Hold on to Nevro (NVRO) Stock for Now | Zacks | 2/4/2020

You follow Analyst Blog - edit You follow Zacks Equity Research - edit What would you like to follow? Zacks Equity Research Cancel Read More Hide Full Article Nevro Corp. ( NVRO - Free Report ) is well-poised for … Per management, the primary competitive factors include company brand recognition, clinical research leadership, pricing and reimbursement. Factors to Bolster Nevro Nevro continues to benefit from sturdy international foothold, thereby driving overall performance. Per management, growth …

Zacks Investment Research

PRA Health Sciences Inc (NASDAQ:PRAH) Shares Acquired by Kornitzer Capital Management Inc. KS | 2/4/2020

… investors own 98.52% of the company’s stock. Get PRA Health Sciences alerts: Several research analysts recently commented on the company. Zacks Investment Research downgraded PRA Health Sciences from a “hold” rating to a “sell” rating … and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations …

PRA Health Sciences Inc (NASDAQ:PRAH) Shares Purchased by Kornitzer Capital Management Inc. KS - Dakota Financial News | 2/4/2020

… of PRA Health Sciences from a “buy” rating to a “hold” rating in a research note on Saturday, January 11th. Zacks Investment Research cut shares of PRA Health Sciences from a “hold” rating to a … and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations …

McKesson Ventures

Lightship Closes $20M Series B Financing Led by McKesson Ventures and Define Ventures and Appoints David MacMurchy as CEO | Business Wire | 2/3/2020

LOS ANGELES–(BUSINESS WIRE)–Feb 3, 2020– Lightship, the premier provider of enterprise level, direct-to-patient clinical research solutions, today announced a $20 million investment led by McKesson Ventures and Define Ventures with participation from Khosla Ventures, Brook Byers, and Marc Benioff and the appointment of David MacMurchy as CEO and Tom Pike as Executive Chairman. “We launched Lightship over a year ago to transform the existing clinical research …

Lightship Closes $20M Series B Financing Led by McKesson Ventures and Define Ventures and Appoints David MacMurchy as CEO | BioSpace | 2/3/2020

Lightship Closes $20M Series B Financing Led by McKesson Ventures and Define Ventures and Appoints David MacMurchy as CEO Published: Feb 03, 2020 Feb. 3, 2020 14:00 UTC LOS ANGELES–( BUSINESS WIRE )– Lightship, the premier provider of enterprise level, direct-to-patient clinical research solutions, today announced a $20 million investment led by McKesson Ventures and Define Ventures with participation from Khosla Ventures, Brook Byers, and Marc Benioff and the …

GHO Capital

FDA grants Medtronic an IDE to study new tech for ablating heart tissue | 1/23/2020

… been associated with other ablation technologies, such as unintended tissue damage,” Verma said in the news release. “The rigorous pre-clinical research to get us to these first procedures has been impressive and we are … companies work together on early research projects combining Exscientia’s proprietary… […] GHO Capital acquires Ardena European specialist investor Global Healthcare Opportunities, also called GHO Capital Partners, recently announced that it has acquired Ardena — a specialist contract …

EuroBiotech Report—Bayer’s phase 3 success, U.K. trial investment, EU fund, MorphoSys and Tissium | FierceBiotech | 11/21/2019

… clinical research. GHO Capital raised a €975 million healthcare investment fund. MorphoSys parted company with its chief scientific officer. Tissium raised €39 million. And more. — Nick Taylor 1. Bayer, Merck’s vericiguat hits endpoint in heart failure phase 3 A phase 3 trial of Bayer and Merck’s vericiguat in heart failure patients has met its primary endpoint. The top-line readout appears to justify the risk the partners took when they …

Maverick Ventures

JPM: Concerto HealthAI unveils $150M raise, t2 pharma data collaborations | FierceBiotech | 1/16/2020

… characteristics of a patient population. The $150 million series B round was led by Declaration Partners with additional backing from Maverick Ventures, AllianceBernstein PCI and SymphonyAI Group. The proceeds will be slated for Concerto’s innovation … revenue gains. “Concerto HealthAI is positioned to empower next-generation clinical research, accelerate breakthrough therapies, and improve patient outcomes.” RELATED: ASCO—Concerto HealthAI uses real-world data to fill the research gap among patients excluded …

Concerto HealthAI Raises $150 Million in Series B Funding | 1/16/2020

… clinical research, accelerate breakthrough therapies, and improve patient outcomes Boston, MA – January 13, 2020 – Concerto HealthAI, the market leader for Real-World Data (RWD) and enterprise AI technology solutions for Precision Oncology, announced today it has raised $150 million in aggregate Series B financing. The round of financing was led by Declaration Partners with participation from Maverick Ventures, AllianceBernstein PCI, and SymphonyAI Group. As part of the transaction, Andrew Goldfarb …

The Carlyle Group

Concerto HealthAI Raises $150 Million in Series B Funding | 1/16/2020

… Ref: Concerto HealthAI) Developer of Real-World Data and enterprise AI technology for Precision Oncology Funding will power next-generation clinical research, accelerate breakthrough therapies, and improve patient outcomes Boston, MA – January 13, 2020 – Concerto … family office of David M. Rubenstein, the Co-Founder of The Carlyle Group. Declaration Partners makes direct private equity and real estate investments, including building platform businesses, providing growth equity capital, seeding early stage private …

Briefcase – January 2020 | 1/15/2020

… Lafayette, Indiana-based contract biosciences research firm, purchased real estate and certain research service assets from Fort Collins-based Pre-Clinical Research Services Inc. PCRS provides laboratory facilities and services for institutions involved in medical … in London, bought the Westminster-based cybersecurity company from the The Carlyle Group (NASDAQ: CG) and The Chertoff Group , which held joint ownership. The deal is expected to close early this year. Independent Bank Group …

Frazier Healthcare Partners

40 GI company developments in 2019 | Becker’s ASC Review | 12/23/2019

… Duodenoscope, marking the first time the agency approved a single-use duodenoscope. TKS 1 made an investment in gastrointestinal-focused clinical research company Objective GI. Advanced Medical Solutions Group acquired surgical sealant company Sealantis. Bloomington … intent to acquire competitor Allergan for $63 billion. Takeda and Frazier Healthcare Partners launched Phathom Pharmaceuticals to develop gastrointestinal treatments. A late-stage study for Gilead Science’s drug to treat fibrosis symptoms associated with nonalcoholic …

What will Clinical Research Look Like in 5, 10, 20 Years? Are We Heading to Heaven, Hell or Purgatory? Part 2 of 4 - Saama Technologies | 11/13/2019

… corporate executive with a successful track record in pharmaceutical research and development. He is currently Entrepreneur in Residence (EIR) at Frazier Healthcare Partners in Palo Alto, CA. This followed a 14-year career at Takeda … as nurturing culture. Jay held the position of SVP, Global Clinical Research & Development Operations at Celgene Corporation and was responsible for leading all Global Clinical R&D Operations functions in support of Celgene sponsored trials …

Goldman Sachs

PRA Health Sciences Inc (NASDAQ:PRAH) Given Average Rating of “Buy” by Analysts - Dakota Financial News | 12/4/2019

… Sciences from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Wednesday, September 4th. Goldman Sachs Group started coverage on PRA Health Sciences in a research note on Thursday … and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations …

Voya Investment Management LLC Boosts Stock Holdings in PRA Health Sciences Inc (NASDAQ:PRAH) | 12/3/2019

… hold” rating and set a $108.00 price target for the company. in a research report on Tuesday, November 5th. Finally, Goldman Sachs Group initiated coverage on PRA Health Sciences in a research report on Thursday … and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations …

Morgan Stanley

Huami Corporation Announced Corporate Mission: Connect Health with Technology | PR Newswire | 12/4/2019

… functionality such as step counting and sleep monitoring, to the cutting-edge AI chip Huangshan-1. According to a recent Morgan Stanley research report, the global health care market was estimated to be six times … the Mayo Clinic and Cleveland Clinic are conducting extensive cooperative clinical research, algorithm development, and AI data training. This collaboration will explore the opportunity to deliver new high-performance ECG form factors to global markets …

First Analysis

Cognition at age 70: Life course predictors and associations with brain pathologies | 12/2/2019

… and head size, TIV was included in all models, as were the demographic and life course factors investigated in the first analysis (sex, age at assessment, childhood cognitive ability, education, and adult SEP). Interactions were … the manuscript. T. Parker is supported by a Wellcome Trust Clinical Research Fellowship (200109/Z/15/Z). C. Lane reports no disclosures relevant to the manuscript. A. Keshavan is supported by a Clinical Research Fellowship …

AbbVie to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at 2019 ASH Annual Meeting | PR Newswire | 11/21/2019

AbbVie to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at 2019 ASH Annual Meeting - AbbVie will present more than 40 abstracts featuring data from approved and investigational medicines … 7:00 a.m. – 8:30 a.m. ET Oral Presentation: 8:15 a.m. ET First Analysis from a Phase 1/2 Study of Venetoclaxin Combination with Daratumumab and Dexamethasone, +/- Bortezomib, in Patients with Relapsed/Refractory Multiple Myeloma Oral Session: 6:15 …

Geisinger

Respiratory Partnering Records 2014-2020: Global Deal Trends, Players and Financials | PR Newswire | 3/11/2020

… Human Services Discovery Laboratories Dizal Pharmaceutical Domainex Dr. Reddy’s Laboratories Drukier Institute for Children’s Health DS Biopharma Ducere Pharma Duke Clinical Research Institute (DCRI) Duke University Eastar Industries ECM Medical Eiger BioPharmaceuticals Electromed Empatica Erasmus … Fujifilm Diosynth Biotechnologies Galapagos Galecto Biotech Galvani Bioelectronics GE Healthcare Geisinger Health System GEn1E Lifesciences Genentech GeneOne Life Science Genome Institute of Singapore Genten Therapeutics German Government Gilead Sciences GlaxoSmithKline Glenmark Pharmaceuticals Government of Australia …

Global Respiratory Partnering Deals Collection, 2014-2020: Trends, Deal Structure, Leading Deals, Most Active Dealmakers | Benzinga | 3/10/2020

… Human Services Discovery Laboratories Dizal Pharmaceutical Domainex Dr. Reddy’s Laboratories Drukier Institute for Children’s Health DS Biopharma Ducere Pharma Duke Clinical Research Institute (DCRI) Duke University Eastar Industries ECM Medical Eiger BioPharmaceuticals Electromed Empatica Erasmus … Fujifilm Diosynth Biotechnologies Galapagos Galecto Biotech Galvani Bioelectronics GE Healthcare Geisinger Health System GEn1E Lifesciences Genentech GeneOne Life Science Genome Institute of Singapore Genten Therapeutics German Government Gilead Sciences GlaxoSmithKline Glenmark Pharmaceuticals Government of Australia …

Scripps Health

Clinical Research Associate / Coordinator - USA-CA-La Jolla | 2/24/2020

upload resume: Profile Clinical Research Associate / Coordinator’,’1040704’,’! !At Scripps Health, you will experience the pride, support, respect that has been repeatedly recognized as one of the nation’s Top 100 Places to Work. You’ll be surrounded by people committed to making a difference in the lives of their patients and their teammates. So if you’re open to change, go ahead and unlock your potential.Scripps Health is committed to providing the …

UnityPoint Health

Hospitals struggle to advance social determinants of health | Modern Healthcare | 2/15/2020

… for something that patients might not feel comfortable discussing—and then figuring out how to use it across their sites. UnityPoint Health, a system based in Iowa, is in the process of rolling out a … called REDCap, which is often used to build databases for clinical research. Henry Ford provided that application—which was updated regularly, as population health coordinators followed up with patients to hone their grocery preferences—to …

MedStar Health

EMBASE Cardiac Update AutoAlert: EPICORE Cardiac Surgery Blogger2 | 2/8/2020

… after catheter and minimally invasive surgical ablation of paroxysmal and early persistent atrial fibrillation: results from the SCALAF trial. Source Clinical Research in Cardiology. 109 (2) (pp 215-224), 2020. Date of Publication: 01 Feb 2020 … Cardiovascular Research Institute of Kansas, Wichita, KS, United States (Asch) MedStar Health Research Institute, Washington, DC, United States (Sharma) Stanford University Medical Center, Stanford, CA, United States (Jilaihawi) NYU Langone Health, New York, NY, United …

MedStar Research and Cerner Partner to Create a Learning Health Network | 2/7/2020

MedStar Health announced that we are the first healthcare system to join the brand new Cerner Learning Health Network . The Cerner Learning Health Network is an innovative, collaborative, platform that will be able to connect healthcare systems and research opportunities. As part of the platform, it will provide investigators at MedStar an opportunity to participate in large clinical research studies, as we will be able to connect with other systems …

Leiden University Medical Center

Preprints can fill a void in times of rapidly changing science - STAT | 1/31/2020

… information, bioRxiv is an example of an open access preprint server for the biological sciences. For the health sciences and clinical research, medRxiv (founded by Yale University, Cold Spring Harbor Laboratories, and the BMJ) and … Researchers from the Netherlands Centre of Infectious Disease Control and Leiden University Medical Center estimated the incubation period of 2019-nCoV. A team from Hokkaido University and the University of Oxford reported the value of …

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis | BMJ | 1/27/2020

… Bochum , Herne , Germany 2 Amsterdam Rheumatology Center , AMC , Amsterdam , The Netherlands 3 Rheumatology , Zuyderland MC , Heerlen , The Netherlands 4 Rheumatology , Leiden University Medical Center , Leiden , The Netherlands 5 Internal Medicine and Rheumatology , Klinikum Bielefeld Rosenhöhe … tools, and to evaluate treatment modalities in order to promote clinical research with the ultimate goal to improve outcome of the disease (ASAS website: www.asas-group.org ). Several unmet needs such as delayed diagnosis and restricted …

Tufts Medical Center

mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s disease | Nature | 1/17/2020

… latency of 144.2 min. Such late-batch participants and highly non-adherent participants are often the subject of anecdotes by clinical researchers employing motor diaries. In the context of studies utilizing paper versions, it may … out at the clinical and translational research center (CTRC) at Tufts Medical Center. Written informed consent was obtained from all participants, all relevant ethical regulations were complied with, and the protocol was approved by the …

Coming to terms with ‘ultra-widefield’ and ‘widefield’ imaging: Page 3 of 3 | Modern Retina | 1/7/2020

Tufts Medical Center and Tufts University School of Medicine, Boston; • K. Bailey Freund, MD, clinical professor of ophthalmology, New York University School of Medicine, and in practice with Vitreous Retina Macula Consultants of New York; • Szilard Kiss, MD, director of clinical research, Department of Ophthalmology, Weill Cornell Medical College; • Giuseppe Querques, MD, associate professor, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy; • David Sarraf, MD, full-time faculty member …

Mercy Health

Bon Secours Mercy Health invests in Lirio artificial intelligence platform | Healthcare IT News | 1/17/2020

… developer of behavior change technology at the J.P. Morgan Healthcare Conference this week. January 17, 2020 11:00 AM Bon Secours Mercy Health has signed an agreement with Tennessee-based behavior change startup Lirio, making a … decisions and take healthy actions,” said Dr. Justin McGoldrick, chief clinical research and innovation officer at Bon Secours Mercy Health, in a statement …

Bon Secours Mercy Health and Lirio Announce Partnership and Investment | PR Newswire | 1/16/2020

Bon Secours Mercy Health and Lirio Announce Partnership and Investment Health system and Artificial Intelligence leader collaborate to drive positive behavior change News provided by Jan 15, 2020, 18:22 ET Share this article CINCINNATI and … decisions and take healthy actions,” said Justin McGoldrick , M.D., chief clinical research and innovation officer at Bon Secours Mercy Health. “This will be central to our health system’s enhanced ability to improve the overall health …

Bon Secours Mercy Health

Bon Secours Mercy Health invests in Lirio artificial intelligence platform | Healthcare IT News | 1/17/2020

… with the developer of behavior change technology at the J.P. Morgan Healthcare Conference this week. January 17, 2020 11:00 AM Bon Secours Mercy Health has signed an agreement with Tennessee-based behavior change startup Lirio … decisions and take healthy actions,” said Dr. Justin McGoldrick, chief clinical research and innovation officer at Bon Secours Mercy Health, in a statement …

Bon Secours Mercy Health and Lirio Announce Partnership and Investment | PR Newswire | 1/16/2020

Bon Secours Mercy Health and Lirio Announce Partnership and Investment Health system and Artificial Intelligence leader collaborate to drive positive behavior change News provided by Jan 15, 2020, 18:22 ET Share this article CINCINNATI and … decisions and take healthy actions,” said Justin McGoldrick , M.D., chief clinical research and innovation officer at Bon Secours Mercy Health. “This will be central to our health system’s enhanced ability to improve the overall health …

NYU Langone Health

New use for an old drug: The potential of colchicine in CVD | 1/16/2020

… Women’s Hospital and Eugene Braunwald Professor of Medicine at Harvard Medical School, told Cardiology Today. Binita Shah, MD, MS, from NYU Langone Health, said colchicine appears to reduce vascular inflammation, but more research is needed … by a VA Career Development Award and an AHA Mentored Clinical Research Award, and the drug was supplied by Takeda Pharmaceuticals and the Manhattan VA Hospital Research Pharmacy. Jolly, Libby, Lloyd-Jones and Mandell report …

Multiple Sclerosis (MS) | 1/13/2020

… lower risk of MS. Further research is needed to confirm whether omega-3 fats are protective against MS and future clinical research should also determine whether supplementation in patients with MS is helpful for reducing … Current Stimulation (tDCS) Leigh Carbet, PhD, a clinical neuropsychologist at NYU Langone Health, is leading a pilot study to determine whether transcranial direct current stimulation (tDCS) can improve fine motor function in people with progressive …

Emory Healthcare

Verily taps Tesla CFO as it looks innovate in value-based care | FierceBiotech | 1/10/2020

… many: better, less expensive care for many people.” Last month, Verily announced separate partnerships with Wake Forest Baptist Health and Emory Healthcare focused on using tech solutions to boost patient outcomes, operational efficiencies and the … believed that if we connected the world of sensors and clinical research with sophisticated computing infrastructure and activated those insights for people with user-friendly platforms, we could improve outcomes and move value-based care …

36 hospitals, health systems that partnered with big tech in 2019 | Becker’s Hospital Review | 12/28/2019

… implement IBM Watson Health Imaging’s Patient Synopsis radiology AI software. 6. Verily launched the Baseline Health System Consortium to make clinical research more accessible for patients, clinicians and researchers. The consortium’s six initial members are … the health and wellness of senior citizens living independently. 17. Emory Healthcare in Atlanta partnered with Verily to use advanced data analytics to improve cost-effectiveness, efficiency and quality. Additionally, many of these health-tech …

Health Net

Invitae (NYSE:NVTA) 2019 financial results: 70% growth in accounts, 60% growth in test volume, 45% growth in revenue year-over-year | 1/13/2020

… variant interpretation capabilities, meaningfully reduce the cost of testing and provide superior customer workflows and patient support. Presented and published clinical research demonstrating the frequency of actionable genetic variants in large patient populations and supporting … United States and internationally: Partnered with the University of Vermont Health Network on a population health testing program to offer proactive genetic screening as part of routine clinical care for patients in Vermont. Announced in …

Invitae preliminary 2019 financial results demonstrate strong momentum with nearly 60% growth in test volume and more than 45% growth in revenue year-over-year | PR Newswire | 1/12/2020

… variant interpretation capabilities, meaningfully reduce the cost of testing and provide superior customer workflows and patient support. Presented and published clinical research demonstrating the frequency of actionable genetic variants in large patient populations and supporting … United States and internationally: Partnered with the University of Vermont Health Network on a population health testing program to offer proactive genetic screening as part of routine clinical care for patients in Vermont . Announced in …

Aetna

Calculating the Costs of Clinical Trials | 12/1/2019

… have to worry about costs could make a big difference.” At the NIH Clinical Center, a hospital devoted entirely to clinical research, the costs of participating in a clinical trial are completely covered, Dr. Millum … and established standards of care for a particular diagnosis.” 5 Aetna’s website stipulates that “all applicable plan limitations for coverage of out-of-network care will apply to routine care costs in clinical trials.” 6 …

Indian Health Service

TelAbortion could ease access woes - New Mexico Political Report | 11/26/2019

… health provider’s time, the medication and a follow up via video, said Ann Firstenberg, Planned Parenthood of the Rocky Mountains’ clinical research coordinator. Planned Parenthood of the Rocky Mountains is the organization offering the study … Amendment, Native Americans cannot get an abortion at their local Indian Health Services clinic. The Hyde Amendment places restrictions on federal dollars paying for abortion except in the event of rape, incest or if the …

Harvard Pilgrim Health Care

Evaluation of the impact of calorie labeling on McDonald’s restaurant menus: a natural experiment | 11/4/2019

… from April through June in each year of data collection. This study was approved by the institutional review board of Harvard Pilgrim Health Care. Participant enrollment We invited all adults (≥18 years), adolescents (11–20 … content at fast food restaurants: cross sectional observational study. BMJ (Clinical research ed). 2013;346:f2907. Google Scholar 3. Franckle RL, Block JP, Roberto CA. Calorie underestimation when buying high-calorie beverages in fast-food …

Understanding childhood obesity in the US: the NIH environmental influences on child health outcomes (ECHO) program | Nature | 10/24/2019

… Diane J. Catellier Division of Chronic Disease Research Across the Lifecourse (CoRAL), Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA Emily Oken Department of Epidemiology, Johns Hopkins … Andrea E. Cassidy-Bushrow Welch Center for Epidemiology, Prevention and Clinical Research, Johns Hopkins University Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA Noel T. Mueller Department of Public Health …

Melinda Gates

Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19 | 3/26/2020

… to the bedside, with specific expertise in vaccines, emerging diseases, biodefense, respiratory viral infections, and sexually transmitted infections. His progressive clinical research experience began in 1981 at Fort Detrick, Frederick, Md., United States, where he … Health, US Army Medical Materiel Development Activity (USAMMDA), the Bill & Melinda Gates Foundation, and others. Dr. Mpanju holds a Ph.D. in Experimental Medicine (Infectious Diseases) from the University of British Columbia, Vancouver, Canada. About Pharm …

Detailed Insights into In Silico/Computer-Aided Drug Discovery Services Market to 2030 - Elaborate Profiles of Key Industry Players - ResearchAndMarkets.com | Malvern Daily Record | 3/26/2020

… leads, which are selected for further investigation during the initial stages of research, are actually translated into product candidates for clinical research studies. Over time, the complexities of drug discovery, have increased; this is especially … LifeSciences BenevolentAI Berkeley Lights Betta Biomedical Industry Fund BIANA Bill & Melinda Gates Foundation BioAscent BioBench Solutions Bioclinica BioDuro BioGlobal Consulting Group BioNTech Biotech Investment Group BIOTEM BMG LABTECH Broad Institute of MIT and Harvard BVCF …

Fred Hutchinson

Healthcare Times - News - HEALTH GUIDE | 3/24/2020

Fred Hutchinson Cancer Research Center has found that a specialized type of immunotherapy — even when used without chemotherapy or radiation — can boost survival from pancreatic cancer, a nearly almost-lethal disease, by more than 75 percent. The findings are so promising, human clinical trials are planned within the next year. The study, led by Drs. Sunil Hingorani and Phil Greenberg, both members of the Clinical Research Division at Fred Hutch …

Data Analyst - Application Support Engineer III - Fred Hutchinson Cancer Research Center - Seattle, WA | 3/24/2020

Share Description Overview Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV … individual who is interested in supporting a large, mission-critical, clinical research data management system used to treat and address cancer. Candidates who are excited about the mission of the Fred Hutchinson Center and cancer …

Anthony Fauci

Coronavirus Disease News 21March 2020 | 3/22/2020

… likely keep Americans at home for several weeks as it runs its course.In a “Today” show interview Friday morning, Dr. Anthony Fauci , director of the National Institute of Allergy and Infectious Diseases, said Americans shouldn’t … with coronavirus, boffins from the University of Queensland Centre for Clinical Research claimed.According to Professor David Paterson , who is leading the research, the drugs have already been shown to wipe out the virus in test …

There isn’t going to be a vaccine in time for COVID-19 | 3/22/2020

… https://thehill.com/homenews/administrat…virus-game When asked on Friday if hydroxychloroquine could be used to prevent COVID-19, Dr. Anthony Fauci, the government’s top infectious disease expert, replied “no.” 10 RE: There isn’t going … Michel Chrétien and Majambu Mbikay, senior researchers at the Montreal Clinical Research Institute (IRCM), have proposed the use of a plant-based compound called quercetin to treat COVID-19. Clinical trials to test its effectiveness …

Gavin Newsom

Google sibling Verily: Coronavirus website has led to over 130 tests so far - CNET | 3/21/2020

… for this week. The website, which went live late Sunday , is hosted through Verily’s Project Baseline, an initiative to advance clinical research. The site lets people in the San Francisco Bay Area take online screener … company said. Before the website launched on Sunday, California Gov. Gavin Newsom said he believed it could be a “national model” for coronavirus testing. Health and Wellness See All • reading Google sibling Verily: Coronavirus website …

UCLA to suspend majority of nonessential on-campus research | 3/21/2020

… clinical research will also be restricted and under review by UCLA Health. Wakimoto asked researchers to prepare for this reduction in on-campus research activity until potentially the end of spring quarter. Other campus facilities have shut down, including libraries and recreational facilities. The decision comes after a “safer at home” order from Los Angeles Mayor Eric Garcetti and a “stay at home” order from California Gov. Gavin Newsom on …

Alex Azar

First Edition: March 20, 2020 | Kaiser Health News | 3/20/2020

… malaria but aren’t approved for the coronavirus, as well as an antiviral drug, remdesivir, that is currently being tested in clinical research on Covid-19, the coronavirus disease. (Burton, Restuccia and Hopkins, 3/19) Financial Times … brought on as its response “coordinator.” Then there’s health secretary Alex Azar, the chair of the Trump administration’s Coronavirus Task Force. And of course, Anthony Fauci, the director of the National Institute of Allergy and …

Thursday, March 19, 2020 | Kaiser Health News | 3/19/2020

… order the supplies. In an executive order issued Wednesday afternoon, Trump granted authority primarily to Health and Human Services Secretary Alex Azar to determine “the proper nationwide priorities” and to allocate all necessary health and … much less or somewhat less likely to enroll in new clinical research trials. And 25% of the sites expect patients currently enrolled in a trial to be much less or somewhat less willing to continue …

Mike Pence

First Edition: March 20, 2020 | Kaiser Health News | 3/20/2020

… malaria but aren’t approved for the coronavirus, as well as an antiviral drug, remdesivir, that is currently being tested in clinical research on Covid-19, the coronavirus disease. (Burton, Restuccia and Hopkins, 3/19) Financial Times … Who, Among The Trump Administration’s Coronavirus Response Team Vice President Mike Pence is in charge of the Trump administration’s response to the coronavirus. But so is Deborah Birx, the physician and diplomat who the Trump …

‘Terrified’ Healthcare Workers Fear Lack of Protection Against COVID-19 | 3/20/2020

… overwhelmed. “If we can’t protect our healthcare workers, they can’t protect the public,” C. Michael Gibson, MD (Baim Institute for Clinical Research, Boston, MA), told TCTMD. “This is really reaching a crisis point.” Gibson put … supply issues. In the United States, for instance, Vice President Mike Pence, who heads the coronavirus task force, this week asked construction companies to donate their N95 masks to local hospitals and stop ordering more …

Joe Biden

Alternative Drugs? Kim/Nick Retain Their Humor. Biden and Israel. | 3/20/2020

… A health official told the Mainichi the drug could be approved as early as May. “But if the results of clinical research are delayed, approval could also be delayed.” Old malaria drug hydroxychloroquine may help … the charge last Sunday in his Democratic primary debate with Joe Biden. Bernie rolled out his usual themes, this time through the virus lens. The pandemic “exposes the incredible weakness and dysfunctionality” of the U.S …

First Edition: March 20, 2020 | Kaiser Health News | 3/20/2020

… malaria but aren’t approved for the coronavirus, as well as an antiviral drug, remdesivir, that is currently being tested in clinical research on Covid-19, the coronavirus disease. (Burton, Restuccia and Hopkins, 3/19) Financial Times … it — and now we’re paying the price.” — Former vice president Joe Biden, in a tweet, March 19, 2019. Several readers have written The Fact Checker, saying they were confused by dueling opinion articles that appeared …

Seth Rogen

Canopy Growth Corp. First THC-Infused Ready-To-Drink Cannabis Beverage Ships Nationwide | 3/17/2020

… dozen countries across five continents. Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars … with leading sector names including cannabis icons Snoop Dogg and Seth Rogen , breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates …

Canopy Growth to temporarily close corporate owned retail amid response to COVID-19 | PR Newswire | 3/17/2020

… dozen countries across five continents. Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars … with leading sector names including cannabis icons Snoop Dogg and Seth Rogen , breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates …

Donald Trump

Alphabet’s Verily says it will launch a limited coronavirus testing website | CNBC | 3/16/2020

… announcement comes after CNBC first reported the website and an internal memo from CEO Sundar Pichai on Friday after President Donald Trump announced the efforts. When asked for additional details after Trump’s press conference, Google … as an initiative that maps health data points used in clinical research to “build the next generation of healthcare tools and services.” The World Health Organization last week declared the coronavirus outbreak a global pandemic …

Alphabet’s Verily launches coronavirus testing website for SF Bay Area | MSN | 3/16/2020

… Donald Trump. The software tool is hosted through Verily’s Project Baseline, an initiative to advance clinical research. It allows people in the Bay Area to take online screener surveys to see if they should go to testing sites in Santa Clara county or San Mateo county for examinations. Along with partnering with the federal government, Verily also worked with the California governor’s office. “We hope that this partnership can scale …

Kamala Harris

Biocom Brings California Companies to Nation’s Capital to Advocate for Rare Disease Research | Business Wire | 3/12/2020

… met with Congressmen Mike Levin and Scott Peters of San Diego and Congressional staff from the offices of California Senator Kamala Harris and Los Angeles Congressman Jimmy Gomez. About Biocom Biocom is the leader and … all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers. For more information on Biocom, please visit our website at www.biocom.org . Connect with us on LinkedIn , Facebook , and …